Summit Therapeutics Inc. Common Stock
$15.61
▼ 0.77
(-4.70%)
Volume: 3,781,917
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
59
- 21d momentum +9.7%
- RSI 47
🎯
Pullback
50
- -5.8% vs 20MA
💎
Value
58
- -47% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)46.6
MACD-0.237
MA trendMixed
ATR6.24%
21d mom.+9.7%
63d mom.+11.4%
vs 20MA-5.8%
RVOL(20)0.62×
52w low · 12
52w high · 29
-46.6% from 52-week high
20d support 13
· resistance 19
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$13.1B
PER—
PBR20.74
PSR—
EPS$-1.07
ROE-135.9%
ROA-113.8%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA-14.46
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| -12.55% | +9.70% | +11.42% | -9.56% | -23.85% | -10.90% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -11.33%, daily vol 4.76%. Summit Therapeutics Inc. Common Stock sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.